AlphaHunt
Healthcare

BAX Stock Analysis

Baxter International Inc. · current price $19.40 (-5.37% today)

★★★ Average 54/ Alpha Score
Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
LAST EARNINGS Baxter International Inc. (BAX)

Latest earnings

EPS
$0.59 vs $0.61 est · -0.0% vs estimate MISS
Revenue
$2.70B · -3.9% YoY
Stock reaction (1M)
+9.6%
Beat streak
2 of last 4 quarters

Key metrics

Alpha Score
54/100
Grade
C
Rev Growth YoY
+2.9%
30-day Momentum
+9.6%
Forward P/E
9.7×
Analyst Target
$21.54
Implied Upside
+11.0%

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA HOLX

View all Healthcare stocks →

BAX — frequently asked

What is BAX's Alpha Score?

Baxter International Inc. (BAX) currently has a TickerMover Alpha Score of 54/100, rated ★★★ Average. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Baxter International Inc. (BAX) a buy?

TickerMover does not give buy or sell recommendations. BAX scores 54/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is BAX's score updated?

BAX's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for BAX →